| Maryam Mandana Asgari, MD | |
|
1665 Aurora Ct, Aurora, CO 80045-2517 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Maryam Mandana Asgari |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 27 Years |
| Location | 1665 Aurora Ct, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962580050 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
Reliv International, Inc. introduced three new products to its Relivables line at the company's national conference here today. The products represent the first extension of the Relivables line since it was introduced last August.
A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. This discovery could help with better patient prognoses and lead to targeted drug treatments for GBM subtypes.
Delivering drugs to the lungs via inhalation has a number of potential advantages over traditional routes of administration like pills or injections. For treating pulmonary diseases, the obvious logic we are applying is topical delivery to the airways via inhalation.
› Verified 2 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
Reliv International, Inc. introduced three new products to its Relivables line at the company's national conference here today. The products represent the first extension of the Relivables line since it was introduced last August.
A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. This discovery could help with better patient prognoses and lead to targeted drug treatments for GBM subtypes.
Delivering drugs to the lungs via inhalation has a number of potential advantages over traditional routes of administration like pills or injections. For treating pulmonary diseases, the obvious logic we are applying is topical delivery to the airways via inhalation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maryam Mandana Asgari, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Maryam Mandana Asgari, MD 1665 Aurora Ct, Aurora, CO 80045-2517 Ph: (720) 848-0000 |
News Archive
In-hospital mortality rates for patients who have atrial fibrillation are significantly higher on the weekend than on weekdays, show US study results.
Reliv International, Inc. introduced three new products to its Relivables line at the company's national conference here today. The products represent the first extension of the Relivables line since it was introduced last August.
A diagnosis of glioblastoma multiforme (GBM) is generally a death sentence, but new research from the University of Wisconsin-Madison lab of Dr. John Kuo shows that at least one subtype is associated with a longer life expectancy. This discovery could help with better patient prognoses and lead to targeted drug treatments for GBM subtypes.
Delivering drugs to the lungs via inhalation has a number of potential advantages over traditional routes of administration like pills or injections. For treating pulmonary diseases, the obvious logic we are applying is topical delivery to the airways via inhalation.
› Verified 2 days ago
Robert Dellavalle, MD Dermatology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Theresa Pacheco, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. Anthony Christos Parris, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Sean T Amsbaugh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1390 S Potomac St, Suite 124, Aurora, CO 80012 Phone: 303-368-8611 Fax: 303-368-9791 | |
Dr. Stanca Ariana Birlea, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0500 Fax: 720-848-0538 | |
Mariah Brown, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1665 Aurora Ct Rm 3004, Aurora, CO 80045 Phone: 720-848-0504 | |
Grant Russell Plost, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |